Olea Medical
Private Company
Total funding raised: $17.5M
Overview
Olea Medical, founded in 2007 and headquartered in La Ciotat, France, is a specialized developer of AI-driven post-processing software for medical imaging, primarily in MRI and CT. Acquired by Canon Medical Systems, the company targets the high-pressure diagnostic environment, especially stroke care, with its automated platform designed to triage cases, quantify key biomarkers, and deliver instant reports to streamline radiology workflows. Its technology aims to reduce time-to-treatment in critical scenarios, supported by educational initiatives like the Olea Medical Academy and a strong focus on standardization and efficiency in radiology departments. As a subsidiary of a major imaging corporation, Olea operates in the commercial stage, integrating its software into the broader medical device ecosystem.
Technology Platform
Intelligent automated software platform for post-processing MRI and CT scans. The flagship Automation Platform V1.5 provides real-time, automated analysis, quantification, and reporting for neurovascular emergencies, integrating with hospital IT systems to streamline radiology workflow.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
The market for AI-driven medical image analysis is crowded. Olea competes with pure-play software companies like Aidoc, Viz.ai, and Brainomix, as well as the in-house software divisions of major imaging equipment manufacturers (Siemens, GE, Philips). Its differentiation lies in its integrated workflow platform and its backing by Canon Medical.